Delee
Delee Corp. offers the CytoCatch™ technology, a duo of systems designed for the efficient isolation and analysis of circulating tumor cells (CTCs). The CytoCatch™ Isolation Platform utilizes a label-free approach based on size and deformability differences to capture CTCs from blood samples, boasting recovery rates above 97% for various cancer cell lines. This platform is fully automated, reducing human error and improving reproducibility. The CytoCatch™ Imaging System complements this by providing advanced computer vision and machine learning for accurate classification and enumeration of isolated CTCs. It offers flexible customization of illumination and filters, dual camera capabilities, and multiple magnifications. The captured cells are compatible with downstream molecular analyses like sequencing and PCR, enabling personalized therapy and disease monitoring.
Delee
Delee Corp. offers the CytoCatch™ technology, a duo of systems designed for the efficient isolation and analysis of circulating tumor cells (CTCs). The CytoCatch™ Isolation Platform utilizes a label-free approach based on size and deformability differences to capture CTCs from blood samples, boasting recovery rates above 97% for various cancer cell lines. This platform is fully automated, reducing human error and improving reproducibility. The CytoCatch™ Imaging System complements this by providing advanced computer vision and machine learning for accurate classification and enumeration of isolated CTCs. It offers flexible customization of illumination and filters, dual camera capabilities, and multiple magnifications. The captured cells are compatible with downstream molecular analyses like sequencing and PCR, enabling personalized therapy and disease monitoring.